CellGenix -Model rh Activin A -Recombinant Human Activin Cells
CellGenix Recombinant Human Activin A reliably promotes definitive endoderm differentiation of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). It in addition maintains the undifferentiated state of ESCs and iPSCs. CellGenix® rh Activin A is produced in our dedicated animal-free facility ensuring maximum safety for optimal use in ATMP manufacturing.
General Information
Activin A belongs to the transforming growth factor beta (TGF-β) superfamily. It regulates a variety of biological functions, including cell proliferation, differentiation, apoptosis and wound repair.
Activin A is used in the cell and gene therapy space to promote differentiation of ESCs and iPSCs into definitive endoderm, and for the maintenance and self-renewal of pluripotent stem cells (PSCs).
GMP Grade
CellGenix® GMP Recombinant Human Activin A is produced following all applicable GMP guidelines and allows for the safe use in accordance with USP Chapter, Ph. Eur. General Chapter 5.2.12 and ISO 20399:2022.
Our GMP cytokines are provided with documented evidence of purity, potency, consistency and stability. In combination with our expert regulatory and technical support this will help simplify your raw material qualification and validation efforts.
- Produced in our dedicated animal-free facility
- Compliant to USPand Ph. Eur. General Chapter 5.2.12 (GMP)
- Seamless transition from preclinical development to ATMP manufacturing
- Differentiation of ESCs and iPSCs into definitive endoderm
- Maintenance and self-renewal of PSCs
Highest GMP Quality Standard
- High lot-to-lot consistency – save time and costs on revalidations
- Performance reliability – rely on consistent product performance
- Highest purity – ensure the safety of your ATMP
- Extremely low endotoxin levels – improve safety and reproducibility
- Expert regulatory & technical support – rely on experience
Read more about our GMP Quality